A more recent study showed that those who stopped treatment with Mounjaro (another GLP-1 drug) similarly regained around 60% of their lost weight
All trials analyzed the composite of 3 major adverse cardiovascular events (MACE), which included cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, except the lixisenatide study that considered 4-point MACE, which also included hospitalization for heart failure (Table 1).5764 Although all the studies with arGLP-1 have demonstrated cardiovascular safety (noninferiority vs
This article covers what tirzepatide is, how its dual agonist mechanism works, what clinical trials have shown, and how it compares to single-agonist peptides like semaglutide
doi: 10.3390/molecules22040628 79
Weve created this guide to help you understand who qualifies for semaglutide and how to ask for it so you can take the first step toward a healthier, more confident you